Insider · CIK 0001350416
Randall Kaye
officer
Files at LBPH (Longboard Pharmaceuticals, Inc.). First filing Oct 16, 2024, latest Oct 16, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $984k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Longboard Pharmaceuticals, Inc. | $984k 16,667 shares | -48% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | UTender of shares Common Stock | -30,554 | $60.00 | $1.8M | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -175,946 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -96,300 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -107,560 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -17,920 | - | - | 0 | Dec 2, 2024 |
| Dec 2, 2024 | LBPH Longboard Pharmaceuticals, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -9,500 | - | - | 0 | Dec 2, 2024 |
| Nov 19, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Common Stock | +30,554 | $6.00 | $183k | 48,474 | Nov 19, 2024 |
| Nov 19, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -30,554 | $0.00 | $0 | 175,946 | Nov 19, 2024 |
| Oct 25, 2024 | LBPH Longboard Pharmaceuticals, Inc. | AGrant or award Retention Restricted Stock Unitsderivative | +9,500 | $0.00 | $0 | 9,500 | Oct 29, 2024 |
| Oct 15, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +16,667 | $4.35 | $73k | 34,587 | Oct 16, 2024 |
| Oct 15, 2024 | LBPH Longboard Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -16,667 | $59.04 | $984k | 17,920 | Oct 16, 2024 |
| Oct 15, 2024 | LBPH Longboard Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -16,667 | $0.00 | $0 | 96,300 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.